title: [Diprivan and asthma].
abstract: Propofol is probably a safe agent in asthmatic patients. In clinical practice, its efficacy in reducing the incidence of peroperative bronchospasm is deemed possible, but has not yet been totally established. With respect to the regression of bronchospasm in a patient receiving propofol, it is not possible to accurately differentiate between the beneficial effects related to the depth of anaesthesia and a specific effect of this agent on bronchial tone. Finally, its haemodynamic effects in case of severe bronchospasm remain to be assessed.
authors.affiliation: Département d'Anesthésie-Réanimation, Hôpital, Bichat, Paris.
authors.forename: B
authors.initials: B
authors.lastname: Dureuil
mesh_terms: D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000150:complications; D001986:Bronchial Spasm / Q000503:physiopathology; D006801:Humans; D015742:Propofol; D013514:Surgical Procedures, Operative
chemical_list: D015742:Propofol
vernacular_title: Diprivan et asthme.